PCCAGEN Stock Latest News
Private CompaniesCagent Vascular Highlights Physician Perspectives on SRT Durability4d agoCAGEN
Private CompaniesCagent Vascular Highlights Serranator SL-PRO Case in Limb-Salvage Procedure5d agoCAGEN
Private CompaniesSerranator Imaging Highlights Serration Therapy in Calcified Vascular Disease6d agoCAGEN
Private CompaniesCagent Vascular Presents Investigational SONIC IVL System at TCT20261w agoCAGEN
Private CompaniesCagent Vascular Webinar to Examine Durable Outcomes for Serration Therapy1w agoCAGEN
Private CompaniesCagent Vascular Highlights Clinical Use of Serranator in Complex CLTI Case2w agoCAGENPrivate CompaniesClinical Use of Cagent Vascular’s Serration Remodeling Therapy in AV Fistula Case2w agoCAGEN
Private CompaniesClinical Evidence Highlights Potential of Serration Remodeling Therapy in Complex EVAR2w agoCAGEN
Private CompaniesCagent Vascular Highlights Serranator Therapy as Differentiated PAD Treatment2w agoCAGEN
Private CompaniesClinical Performance Data Highlights Potential Differentiation for Cagent Vascular1M agoCAGENPrivate CompaniesPeripheral Artery Case Outcome Highlights Use of Cagent Vascular’s Serranator Device1M agoCAGEN
Private CompaniesClinical Durability Spotlight for Serration Remodeling Therapy Could Support Adoption1M agoCAGEN
Private CompaniesSerration Remodeling Therapy Positions Cagent Vascular in Complex PAD Treatment1M agoCAGEN
Private CompaniesCagent Vascular Builds Clinical Momentum for Serration Remodeling Therapy at VIVA 20261M agoCAGEN
Private CompaniesCagent Vascular Highlights Study Data on Serration Remodeling Therapy1M agoCAGEN
Private CompaniesCagent Vascular Showcases Serration Remodeling Therapy at VIVA 20261M agoCAGENPrivate CompaniesVascular Device Firm Highlights Registry Results and Therapy Platform at VIVA 20261M agoCAGEN




